Immunology articles for Canada

Time frame: 1 May 2025 - 30 April 2026
Count: 96

Article ‘Count’ for Immunology.

Journal Count Share
1 0.09
Adrenomedullin Antagonist Nanoparticles Inhibit Breast Cancer Brain Metastasis by Immunomodulating Monocytes/Macrophages 0.09
2 1.33
Stimulator of Interferon Genes Is a Fine-Tuner, but Not a Prime Mover, of Kidney Inflammation 1.00
PGE2 signaling triggers CD31-independent transendothelial migration in vitro and in vivo. 0.33
1 0.02
ARDS Molecular Phenotypes Have Distinct Lower Respiratory Tract Transcriptomes. 0.02
2 0.13
Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (‘Registry’) 0.05
Genetic and epigenetic dysregulation of CR1 is associated with catastrophic antiphospholipid syndrome 0.08
1 0.02
Diagnostic implications and correlates of plasma ADA2 activity and ADA2 variants 0.02
3 0.25
Silencing of PAI-1 using siRNA-lipid nanoparticles reduces thrombosis and prolongs life span in murine models 0.16
Clinical and molecular features of immunodeficiency in patients with telomere biology disorders 0.06
Safety and efficacy of rilzabrutinib vs placebo in adults with immune thrombocytopenia: the phase 3 LUNA3 study 0.03
2 0.83
ChREBP-Mediated Choline Deprivation and Chemokine Secretion Shape Tumor-Associated Macrophages to Promote Immune Evasion 0.01
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 Inactivation. 0.81
2 0.60
Distinct components of mRNA vaccines cooperate to instruct efficient germinal center responses 0.04
Mucosal viral infection elicits long-lived IgA responses via type 1 follicular helper T cells 0.56
1 0.14
Long-chain unsaturated fatty acids released during immune responses stimulate host-microbe trans-kingdom communication 0.14
4 0.99
Respiratory Syncytial Virus Vaccination in Solid Organ Transplant Recipients: Interim Findings From a Phase 3 Trial of mRNA-1345 0.15
Cytomegalovirus-specific cell-mediated immunity for prediction of post-prophylaxis CMV disease in a phase 3 trial of letermovir vs valganciclovir prophylaxis in donor CMV-seropositive recipient CMV-seronegative kidney transplant recipients 0.11
A Phase 3, Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Conjugate Vaccine, in Pneumococcal Vaccine-Naïve Adults 18–64 Years of Age at Increased Risk of Pneumococcal Disease, STRIDE-8 0.06
Virus-Specific T-Cell Therapy for Prophylaxis and Treatment of Cytomegalovirus Infections After Transplantation: a Scoping Review 0.67
1 0.06
Thyroid, Celiac, and Other Autoimmune Diseases and the Risk of Incident Type 1 Diabetes in Young Adulthood. 0.06
2 0.20
Challenging Additivity: Comparing Predicted and Observed AhR Activity of Polycyclic Aromatic Compound (PAC) Mixtures Containing Active and Inactive Constituents 0.13
Aryl Hydrocarbon Receptor Activation Mediates Acute Lethality and Developmental Toxicity of Polychlorinated Diphenyl Ethers in Vertebrates: Mechanistic Insights and Implications for Toxicity Equivalency Factor Frameworks 0.08
1 0.14
Genotyping of selected germline adaptive immune system loci using short-read sequencing data 0.14
4 1.14
Topography of the HLA-A protein enforces shared and convergent immunodominant B cell and antibody alloresponses in transplant recipients 0.07
Primate resident memory T cells activate humoral and stromal immunity 0.05
Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity 0.06
Nociceptor neurons suppress alveolar macrophage-induced Siglec-F+ neutrophil-mediated inflammation to protect against pulmonary fibrosis 0.95
1 0.59
Risk Factors for the Development of Food Allergy in Infants and Children 0.59
1 0.03
Eltrombopag for Newly Diagnosed Pediatric Immune Thrombocytopenia Requiring Treatment 0.03
2 1.07
Mannose-modified hemocyanin enhances pathogen endocytosis by crustacean hemocytes 0.07
Crystal structure and mutagenesis of a nucleic acid–binding BRCT domain in human PARP4 1.00
5 1.25
Pathogen characteristics are key determinants of distinct host response phenotypes of sepsis 0.08
Immobilized IgG-containing immune complexes require platelets to recruit neutrophils during inflammation 0.87
A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection 0.09
Loss of tumor cell MHC class II drives MAPK inhibitor insensitivity of BRAF-mutant anaplastic thyroid cancers 0.06
PIEZO1 mediates mechanical reprogramming of neutrophils for proangiogenic specialization in the lung 0.15
1 0.05
Optimizing Haploidentical Donor Selection for Pediatric Hematopoietic Cell Transplant. 0.05
7 4.09
Chimeric MHC class I– and II–restricted non-self epitopes broaden antitumor T cell reactions 0.19
CD2 and its ligands are involved in development and activation of MAIT cells 0.92
ASXL1 deficiency causes epigenetic dysfunction, combined immunodeficiency, and EBV-associated lymphoma 0.61
A multimorphic variant in ThPOK causes an inborn error of immunity with T cell defects and fibrosis 0.88
Functional targeting of ILC2s and ILC3s reveals selective roles in intestinal fibrosis and homeostasis 0.93
Transient inhibition of type I interferon enhances CD8+ T cell stemness and vaccine protection 0.04
Early Notch signals from fibroblastic reticular cells program effector CD8+ T cell differentiation 0.52
1 0.07
Lack of S100A8 Impairs Lung-Protective Immunity Against Streptococcus pneumoniae 0.07
1 0.18
A single-arm phase 2 trial of an investigational RNA therapeutic to complement factor B sefaxersen for treatment of IgA nephropathy 0.18
1 1.00
Mass Vaccination Scheduling: Trading Off Infections, Throughput, and Overtime 1.00
2 0.98
SLAMF6 as a drug-targetable suppressor of T cell immunity against cancer 0.92
Architecture of the neutrophil compartment 0.06
1 0.04
T follicular helper cells transiently unlock a plasticity state in germinal centre B cells during the humoral immune response 0.04
13 5.08
The GFI1–FOXO1 axis regulates NK cell maturation and function 0.10
Early life exposure to -nitrosamine drives genotoxicity, mutagenesis, and tumorigenesis in DNA repair-deficient mice 0.08
A multi-center clinical trial of allogeneic hematopoietic stem cell transplantation in transfusion-dependent thalassemia 0.03
The genetic driver of Acute Necrotizing Encephalopathy, , regulates the inflammatory response to Influenza A virus infection 0.25
Injured epithelial cell states impact kidney allograft survival after T-cell-mediated rejection 0.07
DOT1L activity limits transcription elongation velocity and favors RNAPII pausing to facilitate mutagenesis by AID 1.00
Primary SARS-CoV-2 exposure by vaccination or infection shapes immune responses to omicron variants among a Spanish cohort 0.03
A scalable reinforcement learning approach for screening large peptide libraries for bioactive peptide discovery 1.00
Deleterious variants in the autophagy-related gene /FIP200 impair immunity to SARS-CoV-2 0.02
Continuous indices to assess the phenotypic spectrum of kidney transplant rejection 0.06
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity 0.73
No evidence of immune exhaustion after repeated SARS-CoV-2 vaccination in vulnerable and healthy populations 1.00
CD200R1-CD200 checkpoint inhibits phagocytosis differently from SIRPα-CD47 to suppress tumor growth 0.69
8 2.64
HLA class I signal peptide variation predicts strength of NKG2A NK cell response to missing-self and risk of human disease 0.08
Reciprocal regulation of fibroblast–macrophage equilibrium governs skin integrity 0.13
Lymphocyte-derived cholinergic circuits modulate germinal center output and B cell activation 0.88
Lymphotoxin-dependent elevated meningeal CXCL13:BAFF ratios drive gray matter injury 0.68
Adenophages are an atypical macrophage population in exocrine glands sustained by ILC2-derived GM-CSF 0.06
Sequential lymphotoxin-β receptor and retinoic acid receptor signals regulate cDC2 fate 0.62
TSLP links intestinal nutrient sensing with amplification of the ILC2–tuft cell circuit 0.13
Chemosensor receptors are lipid-detecting regulators of macrophage function in cancer 0.06
1 0.05
A microRNA-based dynamic risk score for type 1 diabetes 0.05
1 1.00
Association between COVID-19 vaccination and sudden death in apparently healthy younger individuals: A population-based case-control study 1.00
4 1.75
Stepwise differentiation from precursor intermediates and distinct Th1 checkpoints promote CD4 Th1 cell differentiation during chronic viral infection 0.08
Turncoat antibodies unmasked in a model of autoimmune demyelination: From biology to therapy 0.67
Human milk IgA promotes normal immune development by limiting Th17-inducing Erysipelatoclostridium ramosum in the infant gut 0.88
Common inherited loss-of-function mutations in the innate sensor NOD2 contribute to exceptional immune response to cancer immunotherapy 0.11
2 0.05
Macrophage MR1 antigen presentation promotes MAIT cell immunity and lung microbiota modulation 0.01
Cysteinyl leukotrienes stimulate gut absorption of food allergens to promote anaphylaxis in mice 0.04
3 2.58
Persistent antigen is essential for sustaining Leishmania major–specific memory CD4+ T cells and long-term immunity 0.77
Complex I inhibition combined with TLR activation in the breast tumor microenvironment educates cytotoxic neutrophils 0.88
Armored human CAR Treg cells with PD1 promoter-driven IL-10 have enhanced suppressive function 0.93
2 0.24
Bruton’s tyrosine kinase inhibitors rescue neuronal impairment caused by B cell–mediated lymphotoxin-α release 0.20
Donor-recipient mismatch at the SIRPA locus adversely affects kidney allograft outcomes 0.04
2 1.07
Ubiquitin pathway blockade reveals endogenous ADP-ribosylation marking PARP7 and AHR for degradation 0.07
Transcription factor IRF-5 regulates lipid metabolism and mitochondrial function in murine CD8+ T-cells during viral infection. 1.00
1 0.90
Milk IgA promotes symbionts and limits pathobionts in the early life gut 0.90
4 2.01
Functional assessment of a convergent gene network underlying allergic diseases and IgE 0.35
Basophils Activate Oncostatin M Receptor-expressing Vagal Sensory Neurons. 0.75
Autosomal dominant Roquin-1 immunodeficiency and hyper-inflammation 0.71
Autoantibodies in patients with 22q11.2 deletion syndrome and psychosis 0.20
4 0.25
Prime Editing for p47phox-Deficient Chronic Granulomatous Disease 0.15
Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN 0.03
Updated Evidence for Covid-19, RSV, and Influenza Vaccines for 2025–2026 0.04
RSV Prefusion F Vaccine for Prevention of Hospitalization in Older Adults 0.03
1 0.11
Tocilizumab, sarilumab and anakinra in critically ill patients with COVID-19: a randomised, controlled, open-label, adaptive platform trial 0.11

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.